1) Strange timing to post this view - ie wait several weeks and then post within hours of the cf33 1st dosing 2) Taking the time to detail your thoughts indicating that Her-Vaxx results won't be amazing, yet ignore the 'advanced B-cell negotiations' LC has stated just yesterday. 3) Make no comment on the rest of IMU's portfolio and seem to think that one of IMU's smaller assets will tank the share price (even if it didn't report amazing results) despite what is occurring across all the other 'shots on goal (sorry couldn't resist).
Good luck with your profits, but I don't share your sentiments or reasoning.
